Home/Investors/Brandon Capital

Brandon Capital

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

2

Top Stage

Pre-clinical

Investment Focus

Oncology Fibrotic Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Myricx Bio	Pre-clinical	—	Oncology
Actym Therapeutics	Phase 1	—	Oncology, Fibrotic Diseases

Frequent Co-Investors

Illumina Ventures1 shared Sofinnova Partners1 shared Novo Holdings1 shared Cancer Research Horizons1 shared Abingworth1 shared British Business Bank1 shared Boehringer Ingelheim Venture Fund1 shared Eli Lilly and Company1 shared